Tumor‑associated macrophages in lung cancer: Friendly or evil? (Review)
Authors:
Open Access
- 17 September 2020
- journal article
- review article
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 22 (5) , 4107-4115
Abstract
Typically, tumor‑associated macrophages (TAMs), an abundant population of leukocytes in lung cancer, are affected by tumor microenvironment (TME) and shift towards either a pro‑tumor (M2‑like) or an anti‑tumor phenotype (M1‑like). M2‑polarized macrophages, are one of the primary tumor‑infiltrating immune cells and were reported to be associated with the promotion of cancer cell growth, invasion, metastasis, and angiogenesis. TAMs are considered a potential target for adjuvant anticancer therapies, and recent therapeutic approaches targeting the M2 polarization of TAMs have shown encouraging results. The present review discusses recent developments in the role of TAMs in cancer, in particular TAMs functions, clinical implication and prospective therapeutic strategies in lung cancer.Keywords
This publication has 94 references indexed in Scilit:
- A randomised controlled phase II trial of pre-operative celecoxib treatment reveals anti-tumour transcriptional response in primary breast cancerBreast Cancer Research, 2013
- Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to ChemotherapyCancer Discovery, 2011
- Increased IL-10 mRNA expression in tumor-associated macrophage correlated with late stage of lung cancerJournal of Experimental & Clinical Cancer Research, 2011
- Blockade of Notch1 Signaling Alleviates Murine Lupus via Blunting Macrophage Activation and M2b PolarizationThe Journal of Immunology, 2010
- The number and microlocalization of tumor-associated immune cells are associated with patient's survival time in non-small cell lung cancerBMC Cancer, 2010
- The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival timeBMC Cancer, 2010
- Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survivalEuropean Respiratory Journal, 2008
- Exploring the full spectrum of macrophage activationNature Reviews Immunology, 2008
- Human Alveolar Macrophages Are Deficient in PTENJournal of Biological Chemistry, 2006
- Lung cancer in the elderlyEuropean Journal of Cancer, 1997